Get the Stockscreener App
83.33
1.72%
1.41
Pre-market:
83.35
0.02
+0.02%
Transcat Inc stock is traded at $83.33, with a volume of 88,590.
It is up +1.72% in the last 24 hours and down -5.02% over the past month.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
See More
Previous Close:
$81.92
Open:
$82.56
24h Volume:
88,590
Relative Volume:
0.65
Market Cap:
$779.95M
Revenue:
$331.88M
Net Income/Loss:
$5.38M
P/E Ratio:
145.81
EPS:
0.5715
Net Cash Flow:
$19.55M
1W Performance:
+1.98%
1M Performance:
-5.02%
6M Performance:
+7.81%
1Y Performance:
+8.50%
1-Day Range:
$0.00
$0.00
1-Week Range:
$80.47
$87.23
52-Week Range:
$50.23
$100.00
Transcat Inc Stock (TRNS) Company Profile
Name
Transcat Inc
Sector
Industry
Phone
(585) 352-7777
Address
35 VANTAGE POINT DRIVE, ROCHESTER, NY
Compare TRNS vs CTAS, RELX, TRI, CPRT, RBA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRNS
Transcat Inc
|
83.33 | 779.95M | 331.88M | 5.38M | 19.55M | 0.5715 |
CTAS
Cintas Corp
|
225.93 | 89.71B | 11.26B | 2.00B | 1.88B | 4.9083 |
RELX
Relx Plc Adr
|
40.18 | 69.74B | 12.64B | 2.74B | 3.15B | 1.4777 |
TRI
Thomson Reuters Corp
|
122.08 | 52.89B | 7.66B | 1.54B | 2.08B | 3.4015 |
CPRT
Copart Inc
|
29.15 | 27.00B | 4.64B | 1.55B | 1.34B | 1.6051 |
RBA
Rb Global Inc
|
84.69 | 15.68B | 4.72B | 449.90M | 673.97M | 2.158 |
Transcat Inc Stock (TRNS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-26 | Upgrade | Northland Capital | Market Perform → Outperform |
| Aug-05-26 | Downgrade | Northland Capital | Outperform → Market Perform |
| Jul-10-25 | Initiated | Lake Street | Buy |
| Jan-29-25 | Downgrade | Oppenheimer | Outperform → Perform |
| May-22-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Oct-17-23 | Initiated | Oppenheimer | Outperform |
| Sep-15-22 | Initiated | Northland Capital | Outperform |
| May-19-21 | Upgrade | Sidoti | Neutral → Buy |
| Mar-29-21 | Downgrade | Sidoti | Buy → Neutral |
| Jan-19-21 | Initiated | H.C. Wainwright | Buy |
| Sep-17-20 | Resumed | B. Riley FBR | Buy |
| Jul-16-20 | Initiated | Craig Hallum | Buy |
| Jun-15-20 | Initiated | B. Riley FBR | Buy |
| Jan-15-20 | Initiated | Sidoti | Buy |
| Oct-31-19 | Resumed | ROTH Capital | Buy |
| Oct-24-19 | Reiterated | Dougherty & Company | Buy |
| Aug-21-18 | Reiterated | Singular Research | Buy |
| Feb-09-18 | Initiated | ROTH Capital | Buy |
| Nov-15-17 | Initiated | Singular Research | Buy |
| Aug-23-17 | Initiated | Dougherty & Company | Buy |
View All
Transcat Inc Stock (TRNS) Latest News
Transcat (Nasdaq:TRNS)Stock Analysis - Simply Wall Street
Northland upgrades Transcat stock rating on valuation, support By Investing.com - Investing.com Canada
Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time - BioSpace
Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time - Business Wire
Transcat buys USD 12.80 million firm while Transcat stock trades at EUR 72.00 - ad-hoc-news.de
Maintenance and Repair Distributors Stocks Q2 Recap: Benchmarking Transcat (NASDAQ:TRNS) - TradingView
Transcat stock trades at EUR 73.50 with USD 771.0 million value - ad-hoc-news.de
How Transcat Inc. (TRNS) Affects Rotational Strategy Timing - Stock Traders Daily
Transcat grants 1,671 RSUs while analysts rate Transcat stock Reduce - AD HOC NEWS
Transcat stock enters investor meetings after earnings beat estimates - ad-hoc-news.de
Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued - GuruFocus
Transcat, Inc. (TRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Transcat stock gains 2.51 percent as growth meets valuation - AD HOC NEWS
Transcat stock holds at USD 86.00 as earnings growth builds - AD HOC NEWS
Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point (NASDAQ:TRNS) - Seeking Alpha
Precision Trading with Transcat Inc. (TRNS) Risk Zones - Stock Traders Daily
Transcat, Inc. Announces 2026 Annual Meeting Shareholder Voting Results - Kalkine Media
RSU awards lift Transcat (TRNS) director to 2,291 shares - Stock Titan
New RSU grant and vesting reported by Transcat (TRNS) director - Stock Titan
Shareholders at Transcat (TRNS) reelect full board - Stock Titan
Transcat (NASDAQ: TRNS) clears resale of Axiom deal shares - Stock Titan
Transcat Inc (TRNS) Director Oksana Dominach Sells 7,312 Shares - GuruFocus
Transcat Inc Director Oksana Dominach Reports Stock Sale and RSU Grant in September 2026 SEC Filing - Kalkine Media
Transcat Director Sold Shares Worth Over $625K - TradingView
Transcat (TRNS) director sells 7,312 shares; 1,587 RSUs remain - Stock Titan
Transcat (NASDAQ: TRNS) director plans 7,312-share cashless option sale - Stock Titan
List of 20 Acquisitions by Transcat (Sep 2026) - Tracxn
Transcat (TRNS) Q2 2026 Earnings: EPS Smashes Estimates, Yet Shares SlipFinancial Summary - vinanet.vn
Transcat expands biomedical business with $12.8M acquisition - Rochester Business Journal
Transcat, Inc. acquired Southeastern Biomedical Associates, Inc. for $12.8 million. - marketscreener.com
Transcat Names Chief Strategy and Corporate Development Officer - Medical Product Outsourcing
TRNS Looks 20.7% Undervalued on GF Value™ - GuruFocus
Transcat acquires Southeastern Biomedical to expand hospital calibration services - Medical Economics
Transcat Acquires Southeastern Biomedical for $12.8M to Expand Healthcare Services - citybiz
Transcat Acquires Southeastern Biomedical Associates For $12.8 Million - marketscreener.com
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical - Yahoo Finance
Transcat stock holds near record levels after August 4 earnings - ad-hoc-news.de
Hospital equipment services expand across the Southeast in Transcat's $12.8M deal - Stock Titan
Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical - Business Wire
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September - Yahoo Finance
Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September - Business Wire
Transcat (TRNS) Results Check: The Bottom-Line Figure Beats Its Comparison in the Latest Reading; Closing Reaction: Shares Rise 0.88% at the CloseEarnings Seasonality - vinanet.vn
Transcat Inc (TRNS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Transcat (TRNS) Results Check: The Bottom-Line Figure Beats Its Comparison in the Latest Reading; Closing Reaction: Shares Rise 0.88% at the ClosePre-Earnings Setup - dars.gov.et
Transcat director exercises options on 10,000 shares | TRNS Insider Trading - Stock Titan
Transcat's (NASDAQ:TRNS) Conservative Accounting Might Explain Soft Earnings - 富途牛牛
5 Revealing Analyst Questions From Transcat’s Q2 Earnings Call - Yahoo Finance
Transcat (NASDAQ:TRNS) Reaches New 1-Year HighShould You Buy? - MarketBeat
Transcat (NASDAQ:TRNS) Director Sells 504 Shares of Stock - MarketBeat
Transcat Inc (TRNS) director sells 504 shares, reports RSUs and options - Stock Titan
Transcat Inc Stock (TRNS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transcat Inc Stock (TRNS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DePerrior Dawn | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
2,291 |
| Kaniki Mbago M. | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
4,180 |
| Haseley Gary J. | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
40,689 |
| Gillette Christopher P. | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
1,787 |
| Dominach Oksana S. | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
5,933 |
| Cairns Craig D. | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
6,590 |
| Langston Cynthia | Director |
Sep 10 '26 |
Option Exercise |
0.00 |
1,587 |
0 |
3,424 |
| Dominach Oksana S. | Director |
Sep 02 '26 |
Proposed Sale |
85.60 |
7,312 |
625,876 |
0 |
| Dominach Oksana S. | Director |
Sep 02 '26 |
Sale |
85.60 |
7,312 |
625,876 |
4,346 |
| Dominach Oksana S. | Director |
Aug 13 '26 |
Option Exercise |
26.27 |
10,000 |
262,700 |
14,346 |
1.48%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):